Market Overview

Lightning Round: Jim Cramer Weighs In On Bristol-Myers Squibb, Mazor Robotics And More

Share:
Related BMY
Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever
Bristol-Myers Stock May Have Exhausted Its Upside For Now
Douglas Lane & Associates, LLC Buys Oracle Corp, Bank of America Corporation, Macy's Inc, ... (GuruFocus)
Related
38 Biggest Movers From Yesterday
32 Stocks Moving In Thursday's Mid-Day Session

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Bristol-Myers Squibb Co (NYSE: BMY). He said the stock came back and made a new high despite losing a bunch head-to-heads against Keytruda. He likes the stock.

Cramer advised his viewer to hold Mazor Robotics Ltd - ADR (NASDAQ: MZOR) because it's going to be the next Intuitive Surgical, Inc. (NASDAQ: ISRG). He added that problems the company had with Israeli government have passed.

Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) is a speculative stock, thinks Cramer.

Iridium Communications Inc (NASDAQ: IRDM) had a good comeback, but Cramer doesn't see anything that should have driven the stock up so much.

Cramer likes Zagg Inc (NASDAQ: ZAGG) and he thinks there's a lot to the company. He also likes devices that give us more battery life.

Cramer also likes McCormick & Company (NYSE: MKC). He likes its recent acquisition.

Posted-In: mad money Lightning RoundCNBC Jim Cramer Media

 

Related Articles (HIMX + BMY)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...